Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_assertion type Assertion NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_head.
- NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_provenance.
- NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_assertion evidence source_evidence_literature NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_provenance.
- NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_assertion SIO_000772 24092637 NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_provenance.
- NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_assertion wasDerivedFrom befree-20140225 NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_provenance.
- NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_assertion wasGeneratedBy ECO_0000203 NP162889.RAHgte_ti-rRJuLU4b5AvD5Z-G0jq5OczUy4iYrNESPHA130_provenance.